J T Cox

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Reducing the burden of cervical cancer and HPV-related diseases through vaccination. Introduction
    J Thomas Cox
    Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
    Curr Opin Obstet Gynecol 18:s3-4. 2006
  2. ncbi Management of women with cervical cytology interpreted as ASC-US or as ASC-H
    J Thomas Cox
    Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
    Clin Obstet Gynecol 48:160-77. 2005
  3. ncbi Extensive condyloma acuminata treated with imiquimod 5% cream: a case report
    J T Cox
    Department of Student Health Service, University of California at Santa Barbara, CA 93106, USA
    Clin Exp Dermatol 28:51-4. 2003
  4. ncbi The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?
    J Thomas Cox
    Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
    Curr Opin Obstet Gynecol 18:s5-s13. 2006
  5. ncbi Management of women with cervical cancer precursor lesions
    J Thomas Cox
    Gynecology Clinic Health Services, University of California, Santa Barbara, CA 93110, USA
    Obstet Gynecol Clin North Am 29:787-816. 2002
  6. ncbi Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice
    J Thomas Cox
    Women s Clinic, Health Services, University of California, Santa Barbara, CA, USA
    J Natl Compr Canc Netw 2:597-611. 2004
  7. ncbi Using imiquimod for genital warts in female patients
    J Thomas Cox
    Student Health Service, University of California, Santa Barbara, California 93106, USA
    J Womens Health (Larchmt) 13:265-71. 2004
  8. ncbi Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management
    J Thomas Cox
    University of California, Santa Barbara, CA, USA
    Obstet Gynecol Surv 61:S15-25. 2006
  9. ncbi The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors
    J Thomas Cox
    Gynecology Clinic Health Services, University of California, Santa Barbara, CA 93106, USA
    Arch Pathol Lab Med 127:950-8. 2003
  10. ncbi Management of precursor lesions of cervical carcinoma: history, host defense, and a survey of modalities
    J Thomas Cox
    Gynecology Clinic, Health Services University of California, Santa Barbara, CA 93106, USA
    Obstet Gynecol Clin North Am 29:751-85. 2002

Collaborators

Detail Information

Publications28

  1. ncbi Reducing the burden of cervical cancer and HPV-related diseases through vaccination. Introduction
    J Thomas Cox
    Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
    Curr Opin Obstet Gynecol 18:s3-4. 2006
  2. ncbi Management of women with cervical cytology interpreted as ASC-US or as ASC-H
    J Thomas Cox
    Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
    Clin Obstet Gynecol 48:160-77. 2005
  3. ncbi Extensive condyloma acuminata treated with imiquimod 5% cream: a case report
    J T Cox
    Department of Student Health Service, University of California at Santa Barbara, CA 93106, USA
    Clin Exp Dermatol 28:51-4. 2003
    ..Minor inflammatory changes were observed during treatment; however, no significant pain was by reported the patient. No recurrences were reported during 2 years of follow-up...
  4. ncbi The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?
    J Thomas Cox
    Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
    Curr Opin Obstet Gynecol 18:s5-s13. 2006
    ..The epidemiology of HPV infection and a brief introduction to the natural history of HPV infection will be presented here...
  5. ncbi Management of women with cervical cancer precursor lesions
    J Thomas Cox
    Gynecology Clinic Health Services, University of California, Santa Barbara, CA 93110, USA
    Obstet Gynecol Clin North Am 29:787-816. 2002
    ..Until that time, understanding all the issues involved in expectant and in active management of cervical HPV-induced lesions will help provide women with the best care possible...
  6. ncbi Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice
    J Thomas Cox
    Women s Clinic, Health Services, University of California, Santa Barbara, CA, USA
    J Natl Compr Canc Netw 2:597-611. 2004
    ..The gain in sensitivity, apparent cost-effectiveness, and advantage of having a representative specimen for ancillary testing, support the use of LBC...
  7. ncbi Using imiquimod for genital warts in female patients
    J Thomas Cox
    Student Health Service, University of California, Santa Barbara, California 93106, USA
    J Womens Health (Larchmt) 13:265-71. 2004
    ..A reduction in viral load is observed following treatment. Low recurrence rates compared to other treatment modalities may be due to the stimulation of the cell-mediated immune response by imiquimod...
  8. ncbi Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management
    J Thomas Cox
    University of California, Santa Barbara, CA, USA
    Obstet Gynecol Surv 61:S15-25. 2006
    ..Thus, when used properly, HPV testing may reduce morbidity and mortality and do so in a cost-effective manner...
  9. ncbi The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors
    J Thomas Cox
    Gynecology Clinic Health Services, University of California, Santa Barbara, CA 93106, USA
    Arch Pathol Lab Med 127:950-8. 2003
    ..The data and the recommendations for the management of ASC-US, ASC cannot exclude high-grade squamous intraepithelial lesion, and LSIL are discussed...
  10. ncbi Management of precursor lesions of cervical carcinoma: history, host defense, and a survey of modalities
    J Thomas Cox
    Gynecology Clinic, Health Services University of California, Santa Barbara, CA 93106, USA
    Obstet Gynecol Clin North Am 29:751-85. 2002
    ..Of all human cancers, only cervical cancer, once the second most common cancer among women, stands on the threshold of being virtually eliminated...
  11. doi History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results
    J Thomas Cox
    Women s Clinic, University of California Santa Barbara, 93106, USA
    J Clin Virol 45:S3-S12. 2009
    ..zur Hausen's discovery to its present eminent role in both primary cervical cancer screening and abnormal Pap management...
  12. ncbi Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testing
    J T Cox
    Gynecology Clinic, Health Services, Bldg. 588, University of California at Santa Barbara, 93106, USA
    Best Pract Res Clin Obstet Gynaecol 15:715-41. 2001
    ....
  13. ncbi Epidemiology and natural history of HPV
    J Thomas Cox
    Gynecology and Colposcopy Clinic Student Health Service, University of California, Santa Barbara, USA
    J Fam Pract . 2006
    ..If implemented widely, vaccination against HPV promises to dramatically reduce HPV-associated morbidity and mortality...
  14. pmc Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24
    Gaea Moore
    University of California Davis, Sacramento, The Permanente Medical Group, Oakland, CA, USA
    J Low Genit Tract Dis 14:97-102. 2010
    ....
  15. ncbi Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy
    J Thomas Cox
    University of California, Santa Barbara, USA
    Am J Obstet Gynecol 188:1406-12. 2003
    ....
  16. pmc Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping
    Brandon J LaMere
    Regional Laboratory, Kaiser Permanente Northern California, Berkley, CA, USA
    J Virol Methods 151:298-300. 2008
    ..Six-month frozen storage of cervical specimens at alkaline pH had little impact on testing for HPV genotypes among hc2-positive women using this HPV genotyping method...
  17. ncbi Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
    Mark E Sherman
    Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7374, USA
    J Natl Cancer Inst 94:102-7. 2002
    ..Considering age or viral load could improve colposcopy triage...
  18. ncbi 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404, P and S Bldg, 630 W 168th St, New York, NY 10032, USA
    JAMA 287:2120-9. 2002
    ..To provide evidence-based consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors...
  19. ncbi Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404 P and S Building, 630 West 168th Street, New York, NY 10032, USA
    Obstet Gynecol 103:304-9. 2004
    ..If test results of either are abnormal, colposcopy should then be performed. This guidance should assist clinicians in utilizing HPV DNA testing in an effective manner, while minimizing unnecessary evaluations and treatments...
  20. ncbi American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
    Debbie Saslow
    Cancer Control Science Department, American Cancer Society, Altanta, GA, USA
    CA Cancer J Clin 57:7-28. 2007
    ..They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed...
  21. ncbi Chapter 7: Achievements and limitations of cervical cytology screening
    Henry C Kitchener
    Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary s Hospital, Whitworth Park, Manchester, UK
    Vaccine 24:S3/63-70. 2006
    ..The increasing rate of human papillomavirus (HPV) testing and the prospect of prophylactic vaccination will change the way cervical cytology is used, possibly giving way to HPV testing as the primary test in secondary prevention...
  22. ncbi Advances in prevention of cervical cancer and other human papillomavirus-related diseases
    Ian H Frazer
    University of Queensland, Center for Immunology and Cancer Research, Brisbane, QLD 4072, Australia
    Pediatr Infect Dis J 25:S65-81, quiz S82. 2006
  23. doi Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection
    Diane Davis Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA
    J Low Genit Tract Dis 12:71-81. 2008
    ..To provide updated management guidelines according to cervical cytology specimen adequacy and techniques to optimize adequacy based on literature review and expert opinion...
  24. doi An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS)
    Philip E Castle
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Obstet Gynecol 111:847-56. 2008
    ....
  25. ncbi ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, USA
    Am J Clin Pathol 118:714-8. 2002
    ..The management guidelines will help promote optimal and uniform follow-up of women according to Pap test specimen adequacy...
  26. pmc Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology
    Philip E Castle
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Obstet Gynecol 112:637-45. 2008
    ..To examine the predictors of histologic confirmation of high-grade squamous intraepithelial lesion (HSIL) cytology occurring in follow-up of young women originally referred into a trial because of less severe cytology...
  27. ncbi 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, USA
    Am J Obstet Gynecol 189:295-304. 2003
    ....
  28. ncbi HPV prevention and the promise of the new vaccines
    Stephen Allred
    Oregon Adult Immunization Coalition Portland, USA
    J Am Acad Nurse Pract 18:1-11. 2006